Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stefan Bracht is active.

Publication


Featured researches published by Stefan Bracht.


Molecular Pharmaceutics | 2018

Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate

Yipshu Pui; Yuejie Chen; Huijun Chen; Shan Wang; Chengyu Liu; Wouter Tonnis; Linc Chen; Peter Serno; Stefan Bracht; Feng Qian

Amorphous solid dispersion (ASD) is one of the most versatile supersaturating drug delivery systems to improve the dissolution rate and oral bioavailability of poorly water-soluble drugs. PVP based ASD formulation of nimodipine (NMD) has been marketed and effectively used in clinic for nearly 30 years, yet the mechanism by which PVP maintains the supersaturation and subsequently improves the bioavailability of NMD was rarely investigated. In this research, we first studied the molecular interactions between NMD and PVP by solution NMR, using CDCl3 as the solvent, and the drug-polymer Flory-Huggins interaction parameter. No strong specific interaction between PVP and NMD was detected in the nonaqueous state. However, we observed that aqueous supersaturation of NMD could be significantly maintained by PVP, presumably due to the hydrophobic interactions between the hydrophobic moieties of PVP and NMD in aqueous medium. This hypothesis was supported by dynamic light scattering (DLS) and supersaturation experiments in the presence of different surfactants. DLS revealed the formation of NMD/PVP aggregates when NMD was supersaturated, suggesting the formation of hydrophobic interactions between the drug and polymer. The addition of surfactants, sodium lauryl sulfate (SLS) or sodium taurocholate (NaTC), into PVP maintained that NMD supersaturation demonstrated different effects: SLS could only improve NMD supersaturation with concentration above its critical aggregation concentration (CAC) value while not with lower concentration. Nevertheless, NaTC could prolong NMD supersaturation independent of concentration, with lower concentration outperformed higher concentration. We attribute these observations to PVP-surfactant interactions and the formation of PVP/surfactant complexes. In summary, despite the lack of specific interactions in the nonaqueous state, NMD aqueous supersaturation in the presence of PVP was attained by hydrophobic interactions between the hydrophobic moieties of NMD and PVP. This hydrophobic interaction could be disrupted by surfactants, which interact with PVP competitively, thus hindering the capability of PVP to maintain NMD supersaturation. Therefore, caution is needed when evaluating such ASDs in vitro and in vivo when various surfactants are present either in the formulation or in the surrounding medium.


Archive | 2004

Transdermal delivery of hormones without the need of penetration enhancers

Thomas Langguth; Stefan Bracht; Michael Dittgen; Petra Huber; Dirk Schenk


Archive | 2006

Solid transdermal therapeutic system comprising uv absorber

Thomas Langguth; Stefan Bracht


Archive | 2012

Osmotically active vaginal delivery system

Manja Ahola; Stefan Bracht; Harri Jukarainen; Pirjo Kortesuo; Heikki Lyytikäinen; Mikael Stolt


Archive | 2017

sistema de dispensa vaginal osmoticamente ativo

Harri Jukarainen; Heikki Lyytikäinen; Manja Ahola; Mikael Stolt; Pirjo Kortesuo; Stefan Bracht


Archive | 2017

sistema de liberação de fármaco contendo progestina

Adrian Funke; Ildiko Terebesi; Sascha General; Stefan Bracht


Archive | 2013

SISTEMA DE ADMINISTRACION VAGINAL OSMOTICAMENTE ACTIVO

Stefan Bracht; Pirjo Kortesuo; Mikael Stolt; Manja Ahola; Harri Jukarainen; Heikki Lyytikinen


Archive | 2013

Transdermal delivery of hormones with low concentration of penetration enhancers

Thomas Langguth; Stefan Bracht; Michael Dittgen; Petra Huber; Dirk Schenk


Archive | 2012

Système d'administration vaginale osmotiquement actif

Stefan Bracht; Manja Ahola; Harri Jukarainen; Pirjo Kortesuo; Heikki Lyytikäinen; Mikael Stolt


Archive | 2011

SYSTÈMES THÉRAPEUTIQUES TRANSDERMIQUES À FEUILLE DE PROTECTION INHIBANT LA CRISTALLISATION (RELEASE LINER)

Stefan Bracht; Ildiko Terebesi; Thomas Langguth

Collaboration


Dive into the Stefan Bracht's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ildiko Terebesi

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Drik Schenk

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge